Burlando, M.; Fabbrocini, G.; Marasca, C.; Dapavo, P.; Chiricozzi, A.; Malvaso, D.; Dini, V.; Campanati, A.; Offidani, A.; Dattola, A.;
et al. Adalimumab Originator vs. Biosimilar in Hidradenitis Suppurativa: A Multicentric Retrospective Study. Biomedicines 2022, 10, 2522.
https://doi.org/10.3390/biomedicines10102522
AMA Style
Burlando M, Fabbrocini G, Marasca C, Dapavo P, Chiricozzi A, Malvaso D, Dini V, Campanati A, Offidani A, Dattola A,
et al. Adalimumab Originator vs. Biosimilar in Hidradenitis Suppurativa: A Multicentric Retrospective Study. Biomedicines. 2022; 10(10):2522.
https://doi.org/10.3390/biomedicines10102522
Chicago/Turabian Style
Burlando, Martina, Gabriella Fabbrocini, Claudio Marasca, Paolo Dapavo, Andrea Chiricozzi, Dalma Malvaso, Valentina Dini, Anna Campanati, Annamaria Offidani, Annunziata Dattola,
and et al. 2022. "Adalimumab Originator vs. Biosimilar in Hidradenitis Suppurativa: A Multicentric Retrospective Study" Biomedicines 10, no. 10: 2522.
https://doi.org/10.3390/biomedicines10102522
APA Style
Burlando, M., Fabbrocini, G., Marasca, C., Dapavo, P., Chiricozzi, A., Malvaso, D., Dini, V., Campanati, A., Offidani, A., Dattola, A., Caro, R. D. C., Bianchi, L., Venturini, M., Gisondi, P., Guarneri, C., Malara, G., Trifirò, C., Malagoli, P., Fargnoli, M. C.,
... Parodi, A.
(2022). Adalimumab Originator vs. Biosimilar in Hidradenitis Suppurativa: A Multicentric Retrospective Study. Biomedicines, 10(10), 2522.
https://doi.org/10.3390/biomedicines10102522
